Research Profiles
Olawale O. Amubieya, MD, PhD
Social and environmental factors and their impacts on advanced lung diseases and lung transplant.
Igor Barjaktarevic, MD, PhD
Lawrence N. Benjamin, MD
Implementation and outcomes research for lung cancer screening.
Russell G. Buhr, MD, PhD
Developing and evaluating programs and policies to improve care to patients with asthma and COPD.
Steven Y. Chang, MD, PhD
Investigator in multicenter trials of: sepsis, shock, and acute respiratory failure (including ARDS).
Christopher B. Cooper, MD
Research activities: respiratory physiology, exercise physiology and obstructive pulmonary diseases.
Ana C. Costa Monteiro, MD, PhD
Identifying poor prognosticators of ARDS by leveraging translational and clinical data.
Brett Dolezal, PhD
Exercise Physiology research including cardiopulmonary exercise testing & pulmonary rehabilitation.
Tamas Dolinay, MD
Prolonged mechanical ventilation, mechanical ventilator liberation, ARDS care and outcomes.
Patricia H. Eshaghian, MD
Interests are in Cystic Firbosis and Bronchiectasis and PCD.
Tomas Ganz, MD, PhD
Molecular basis of systemic iron metabolism and its disorders from biochemistry to animal models.
Jason Hong, MD, PhD
Integrative multiomics and basic/translational research in pulmonary arterial hypertension.
Nikita Jambulingam, MD
Cost-effectiveness of telehealth services in sleep medicine.
Kristin Schwab Jensen, MD
Post-ICU Recovery, Pulmonary Rehabilitation, Medical Education in the ICU.
Airie Kim, MD, PhD
The roles of iron and erythropoietic homeostasis and dysregulation in inflammatory lung diseases.
Kostyantyn Krysan, PhD
Mechanisms of lung cancer progression from premalignancy to invasive disease.
Bin Liu
Targeted and immunotherapy for non-small cell lung cancer and mechanisms of immunosuppression.
Jennifer McCaney, PhD
Medical device innovation and regulation; entrepreneurship and venture capital in the life sciences.
Kathryn H. Melamed, MD
Medical education, curriculum development, and assessment.
Nida Qadir, MD
Practice variability in ARDS and long-term outcomes after critical illness.
Michael D. Roth, MD
1) Tumor immunotherapy, 2) Inhalation toxicology, 3) Scleroderma-related interstitial lung disease.
Ramin Salehirad, MD, PhD
We study lung cancer immunopathogenesis and develop therapies to overcome resistance.
Yusaku M. Shino, MD
Development of novel methods to assess the immune system after lung transplantation.
Grant Turner, MD
Clinical trials, quality improvement in cystic fibrosis, lung transplantation, and LGBTQIA+ health.
B. Corbett Walsh, MD, MBE
Bioethics, complex communication, disaster medicine, unrepresented patients, ECMO.
Tisha S. Wang, MD
Clinical/translational research within rare lung disease, focused on pulmonary alveolar proteinosis.
S. Samuel Weigt, MD
Clinical and translational research in lung transplantation and interstitial lung disease.
Eric Yen, MD, MS
Research on socioeconomic, environmental, and biological factors contributing to health disparities.